Alvespimycin hydrochloride
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Alvespimycin hydrochloride, covering 2013-04-10 to 2015-11-04. Get the full timeline:
Most recent: Clinical Trial Update: Alvespimycin Hydrochloride in Treating Patients With Relapsed Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, or B-Cell Prolymphocytic Leukemia [Phase 1]